Amlodipine induced gingival hyperplasia: a case report
نویسندگان
چکیده
منابع مشابه
Gene Polymorphism in Amlodipine Induced Gingival Hyperplasia: A Case Report
The management of cardiovascular disorders poses a dilemma for the medical fraternity. Calcium channel blockers are one of the most commonly used drugs for the management of this disorder, and it is also a well known fact that they are one of the most common group of drugs responsible for causing gingival over growth as one of their adverse effects. Amlodipine is a new generation hypertensive, ...
متن کاملAmlodipine Induced Gingival Hyperplasia
Amlodipine is a calcium channel blocker. Because of its long acting effect it is being widely used as antihypertensive drug. Gingival hyperplasia is one of its side effects. The histological and clinical evidences were consistent with amlodipine-induced gingival hyperplasia. The aim of publishing this report is to draw the attention of dentists towards this adverse effect.
متن کاملAmlodipine-induced gingival hyperplasia.
Gingival hyperplasia can occur during use of drugs such as diphenylhydantoin, cyclosporine and nifedipine. We report, three cases of gingival hyperplasia induced by amlodipine, a second generation calcium channel blocker. Exact cause of induction of thehyperplasia is not known. Individual variation in metabolism of the drug may be a factor.
متن کاملAmlodipine-induced gingival hyperplasia.
Drug-induced gingival hyperplasia is a serious concern both for the patient and the clinician. A 45 year-old Caucasian male patient with hypertension, who received amlodipine (10 mg/day, single dose orally) for two months, sought medical attention because of the new-onset gingival enlargement. On clinical examination a generalized and firm overgrowth of the gingival throughout the maxilla and t...
متن کاملUntypical Amlodipine-Induced Gingival Hyperplasia
Amlodipine is a third generation dihydropyridine calcium channel blocker that is frequently used in therapy of hypertension. Among many side effects, amlodipine has been found associated with gingival overgrowth (GO) which usually occurs within the first three months of starting therapy at a dose of 10 mg/day. However, there are very few reports on amlodipine-induced gingival overgrowth (AIGO) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Basic and Clinical Pharmacology
سال: 2015
ISSN: 2319-2003
DOI: 10.18203/2319-2003.ijbcp20150396